Identification and characterization of the promoter of fibroblast activation protein

Por Zhang, Jiping, Valianou, Matthildi, Cheng, Jonathan D.
Publicado em 2010

Review of docetaxel in the treatment of gastric cancer

Por Tetzlaff, Eric D, Cheng, Jonathan D, Ajani, Jaffer A
Publicado em 2008

Thromboembolism in Gastrointestinal Cancers

Por Tetzlaff, Eric D., Cheng, Jonathan D., Ajani, Jaffer A.
Publicado em 2008

Selective Fluorescence Probes for Dipeptidyl Peptidase Activity - Fibroblast Activation Protein and Dipeptidyl Peptidase IV

Por Lai, Koon Siew, Ho, Nan-Hui, Cheng, Jonathan D., Tung, Ching-Hsuan
Publicado em 2007

FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells

Por Lee, Hyung-Ok, Mullins, Stefanie R, Franco-Barraza, Janusz, Valianou, Matthildi, Cukierman, Edna, Cheng, Jonathan D
Publicado em 2011

Evolution of Tumor Invasiveness: The Adaptive Tumor Microenvironment Landscape Model

Por Lee, Hyung-Ok, Silva, Ariosto S., Concilio, Susanna, Li, Yue-Sheng, Slifker, Michael, Gatenby, Robert A., Cheng, Jonathan D.
Publicado em 2011

An Activatable Near Infrared Fluorescent Probe for In Vivo Imaging of Fibroblast Activation Protein-alpha

Por Li, Jinbo, Chen, Kai, Liu, Hongguang, Cheng, Kai, Yang, Meng, Zhang, Jiping, Cheng, Jonathan D., Zhang, Yan, Cheng, Zhen
Publicado em 2012

Photodynamic Molecular Beacon Triggered by Fibroblast Activation Protein on Cancer-associated Fibroblasts for Diagnosis and Treatment of Epithelial Cancers

Por Lo, Pui-Chi, Chen, Juan, Stefflova, Klara, Warren, Michael S., Navab, Roya, Bandarchi, Bizhan, Mullins, Stefanie, Tsao, Ming, Cheng, Jonathan D., Zheng, Gang
Publicado em 2009

Long-Term Results of Concomitant Boost Radiation plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: a Phase II Trial of the Radiation Therapy Oncology Group (RTOG 99-...

Por Garden, Adam S., Harris, Jonathan, Trotti, Andy, Jones, Christopher U., Carrascosa, Luis, Cheng, Jonathan D., Spencer, Sharon S., Forastiere, Arlene, Weber, Randal S., Ang, K. Kian
Publicado em 2008

Influence of Diabetes on the Interpretation of PET Scans in Patients With Esophageal Cancer

Por Haley, Michael, Konski, Andre, Li, Tianyu, Cheng, Jonathan D., Maurer, Alan, Haluszka, Oleh, Scott, Walter, Meropol, Neal J., Cohen, Steven J., Freedman, Gary
Publicado em 2009

Identification of inhibitory scFv antibodies targeting fibroblast activation protein utilizing phage display functional screens

Por Zhang, Jiping, Valianou, Matthildi, Simmons, Heidi, Robinson, Matthew K., Lee, Hyung-Ok, Mullins, Stefanie R., Marasco, Wayne A., Adams, Gregory P., Weiner, Louis M., Cheng, Jonathan D.
Publicado em 2013

Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold

Por Jansen, Koen, Heirbaut, Leen, Cheng, Jonathan D., Joossens, Jurgen, Ryabtsova, Oxana, Cos, Paul, Maes, Louis, Lambeir, Anne-Marie, De Meester, Ingrid, Augustyns, Koen, Van der Veken, Pieter
Publicado em 2013

Correlation of molecular response as measured by 18-FDG PET with outcome after chemo-radiation in patients with esophageal carcinoma

Por Konski, Andre A., Cheng, Jonathan D., Goldberg, Melvyn, Li, Tianyu, Maurer, Alan, Yu, Jian Q., Haluszka, Oleh, Scott, Walter, Meropol, Neal J., Cohen, Steven J., Freedman, Gary, Weiner, Louis M.
Publicado em 2007

A Phase II Trial of the Proteasome Inhibitor Bortezomib in Patients with Advanced Biliary Tract Cancers*

Por Denlinger, Crystal S., Meropol, Neal J., Li, Tianyu, Lewis, Nancy L., Engstrom, Paul F., Weiner, Louis M., Cheng, Jonathan D., Alpaugh, R. Katherine, Cooper, Harry, Wright, John J., Cohen, Steven J.
Publicado em 2014

Phase II and Coagulation Cascade Biomarker Study of Bevacizumab with or without Docetaxel in Patients with Previously Treated Metastatic Pancreatic Adenocarcinoma

Por Astsaturov, Igor A., Meropol, Neal J., Alpaugh, R. Katherine, Burtness, Barbara A., Cheng, Jonathan D., McLaughlin, Sue, Rogatko, André, Xu, Zhiheng, Watson, James C., Weiner, Louis M., Cohen, Steven J.
Publicado em 2011

Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in (18)F-FDG PET determination of myocardial activity after chemoradiotherapy for es...

Por Konski, Andre, Li, Tianyu, Christensen, Michael, Cheng, Jonathan D, Yu, Jian Q, Crawford, Kevin, Haluszka, Oleh, Tokar, Jeffrey, Scott, Walter, Meropol, Neal J, Cohen, Steven J, Maurer, Alan, Freedman, Gary M
Publicado em 2012

Induction therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil and Radiotherapy Followed...

Por Boland, Patrick M, Meyer, Joshua E, Berger, Adam C, Cohen, Steven J, Neuman, Tzahi, Cooper, Harry S, Olszanski, Anthony J, Davey, Monica, Cheng, Jonathan D, Lebenthal, Abraham, Burtness, Barbara A, Scott, Walter J, Astsaturov, Igor A
Publicado no Am J Clin Oncol (2017)